Profile
Jonathan Neely is currently VP-Investor Relations & Business Development at OptiNose, Inc. since 2020 and Investor Relations Contact at DBV Technologies SA starting in 2025.
Former positions include Director-Financial, Planning, Analysis & IR at Endo LP and Head-Investor Relations & Corporate Communications at Axovant Sciences, Inc. from 2015 to 2017.
Education includes undergraduate and graduate degrees from the University of Pittsburgh.
Jonathan Neely active positions
| Companies | Position | Start |
|---|---|---|
| OPTINOSEPAR | Investor Relations Contact | 2020-07-31 |
| DBV TECHNOLOGIES | Investor Relations Contact | 2025-11-30 |
Former positions of Jonathan Neely
| Companies | Position | End |
|---|---|---|
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Investor Relations Contact | 2017-09-30 |
| ENDO, INC. | Director of Finance/CFO | - |
Education of Jonathan Neely
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
OptiNose, Inc.
OptiNose, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes products for patients treated by ear, nose, throat and allergy diseases | Health Technology |
University of Pittsburgh
University of Pittsburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DBV Technologies SA
DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy | Health Technology |
Endo, Inc.
Endo, Inc. Pharmaceuticals: MajorHealth Technology Manufactures branded and generic pharmaceuticals & sterile injectables | Health Technology |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Jonathan Neely
















